Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - TAX PROVISION
Tax Provision DNLI - Denali Therapeutics Inc.
30 K
LAST VALUE
43.25%
2 YEAR CAGR
-68.79%
5 YEAR CAGR
0.00%
10 YEAR CAGR